(via TheNewswire)

• CEO Meets with Mining and Health Executives in South America to discuss deployment of new drug and alcohol screening solution.  

• Mining deployment of the technology would disrupt drug and alcohol testing in the mining industry and represents a massive global opportunity for the Company.  

• Voice activated solution would enable drug and alcohol screening at the gate and at scale.  

Vancouver, British Columbia – TheNewswire - February 2, 2026 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “ Company ” or “ MindBio ”), a biotechnology company that conducts clinical health research and has developed a world first AI prediction tool for drug and alcohol intoxication detection by a simple analysis of the voice, is pleased to announce its CEO, Justin Hanka has met with mining and health executives in South America, to discuss potential deployment of the Company’s technology into the mining industry.  

The Company has been showcasing its technology as an enterprise solution and has led to interest from mining and health officials in South America, who are interested in deploying the Company’s intoxication technology “at the gate” as a first line screen for multiple substances such as alcohol, hallucinogens, amphetamines, cocaine and cannabis.  

MindBio is investing heavily in developing its proprietary drug and alcohol prediction technologies for use at scale in enterprise environments.  The platform technology in development has wide applications particularly in employment situations, such as in the mining industry where broad screening for drug and alcohol intoxication in mining workers in South America is government mandated.  Alcohol and drug testing in the mining industry at scale is currently slow, expensive, time consuming and personally invasive (ie. Involves collecting saliva, urine or blood samples plus breath tests).  Drug and alcohol testing is an essential aspect of ensuring the health and safety of workers and preventing accidents that can cause massive delays and cost blow outs from a single avoidable accident.  One accident can cost a mining company hundreds of millions in delayed production, site boycotts by unions, insurance and medical expenses.

National workforce studies in Chile alone, show that alcohol consumption among mining workers exceeds 75% and the proportion of problem drinkers is above 40% with drug use estimated in 9% of the more than 200,000 mining workers in the country, (ACHS, 2012: SENDA, 2024).  And internationally more than 20-25% of all occupational accidents are directly or indirectly linked to substance use, (International Labour Organization 1996, 2022: Gomez et al, 2002).  This translates to tens of thousands of preventable workplace incidents related to drug and alcohol intoxication.

The Company’s core technology can reliably predict intoxication with hallucinogens and alcohol by analysing voice.  The Company plans to expand its algorithms to be able to detect other prohibited drugs that are difficult to detect particularly at scale and volume and require specialised equipment, with MindBio’s solution provided by a simple analysis of the voice over its proprietary AI platform.

The Company’s CEO Justin Hanka said, “We are delighted by the commercial interest in our core technology by the mining industry and will work with our counterparts in South America to develop and deploy an appropriate solution for the region which represents a massive opportunity for the Company to disrupt drug and alcohol testing  processes in the mining industry globally”.

For further information, please contact:

Justin Hanka, Chief Executive Officer

61 433140886

justin@mindbiotherapeutics.com

www.mindbiotherapeutics.com

About MindBio Therapeutics

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) is a biotechnology company headquartered in Vancouver, British Columbia, that for several years has been conducting drug and alcohol research and has created health prediction technologies using AI and machine learning.  The Company has expertise in using speech analytics as a prediction tool for drug and alcohol intoxication and has created a world first voice and AI powered prediction model for drug and alcohol intoxication for use in consumer and enterprise situations.  The Company is developing a comprehensive enterprise platform using voice and powered by AI for use in detecting drug and alcohol intoxication in workplaces, law enforcement, mental health and telehealth.

Cautionary Note Concerning Forward-Looking Statements:

The press release contains "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "budget," "believe," "project," "estimate," "expect," "scheduled," "forecast," "strategy," "future," "likely," "may," "to be," "could," "would," "should," "will" and similar references to future periods or the negative or comparable terminology, as well as terms usually used in the future and conditional. Forward-looking statements are based on assumptions as of the date they are provided. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

Additionally, there are known and unknown risk factors that could cause the Company's actual results and financial conditions to differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important risk factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements, include among others: general economic, market and business conditions in Canada and Australia; market volatility; unforeseen delays in timelines for any of the transactions or events described in this press release.  All forward-looking information is qualified in its entirety by this cautionary statement.

The Company disclaims any obligation to revise or update any such forward-looking statement or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2026 TheNewswire - All rights reserved.